Streetbeat News

VAXX

Vaxxinity Inc

vaxxinity.com

Employees

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

vaccines against chronic diseases

Open

0.00

Mkt cap

25K

Volume

1.7K

High

0.00

P/E Ratio

N/A

52-wk high

1.10

Low

0.00

Div yield

N/A

52-wk low

0.00

U.S. stocks saw significant gains with the Dow Jones surging over 400 points following the release of April's job report, which showed a lower-than-expected addition of 175,000 nonfarm payrolls. The unemployment rate slightly increased to 3.9%. Notably, Safe & Green Holdings Corp. (SGBX) shares soared 70% after announcing a delivery to a quick-service restaurant, Vaxxinity, Inc. (VAXX) surged 33% post-delisting announcement, and WideOpenWest, Inc. (WOW) gained 29% after a purchase proposal. Conversely, AEON Biopharma, Inc. (AEON) plummeted 51% due to disappointing trial results, Sprout Social, Inc. (SPT) fell 30% after reporting poor revenue, and Marin Software Incorporated (MRIN) dropped 19% due to a revenue decline.

Portfolio Pulse from Avi Kapoor

May 03, 2024 | 1:44 pm

In Friday's pre-market session, several healthcare stocks showed significant movement. Helius Medical Tech led the gainers with a 48.9% increase, while AEON Biopharma experienced the largest drop among the losers, declining by 44.4%. Notably, Ardelyx and Owens & Minor reported their Q1 earnings, contributing to their stock increases.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 12:06 pm

Apple Inc. shares surged 6% in pre-market trading after announcing better-than-expected Q2 results, a $110-billion stock buyback program, and a dividend increase. Other stocks also moved significantly in pre-market trading, with notable gainers including Vaxxinity, El Pollo Loco, AXT, Inc., and Amgen Inc., each reporting positive financial results or corporate actions. Conversely, companies like NanoVibronix, Sprout Social, and Stem, Inc. saw declines due to disappointing financial results or corporate developments.

Portfolio Pulse from Avi Kapoor

May 03, 2024 | 9:57 am

In Tuesday's intraday session, several health care stocks experienced significant movements. Akili, Cyclacel Pharmaceuticals, Eliem Therapeutics, GeneDx Hldgs, Dare Bioscience, and Lucid Diagnostics were among the gainers, with Akili leading at a 70.1% increase. On the downside, NRX Pharmaceuticals, Innovative Eyewear, Vaxxinity, Barinthus Biotherapeutics, Annovis Bio, and OpGen saw notable declines, with NRX Pharmaceuticals dropping by 23.9%.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:31 pm

In Monday's after-market session, several health care stocks showed notable movements. GeneDx Holdings led the gainers with a 21.8% increase following their Q1 earnings release, while GlucoTrack experienced the largest decline among the losers, dropping 10.7%. Other notable movers included InnovAge Holding, Mustang Bio, and Vaxxinity, each responding to market dynamics and company-specific news.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 8:31 pm

Teledyne Technologies shares fell by 9% after reporting disappointing Q1 financial results and cutting FY24 EPS guidance. Other stocks showed significant movement, with notable gainers including Chicken Soup for the Soul Entertainment and BranchOut Food, and losers like Neo-Concept International and iSun.

Portfolio Pulse from Avi Kapoor

April 24, 2024 | 5:57 pm

Health care stocks showed significant movement in Wednesday's intraday session, with notable gainers including Catheter Precision, Prenetics Global, and Alterity Therapeutics, among others. On the downside, GlucoTrack, Evotec, and Vaxxinity led the losers, with Evotec and Addex Therapeutics specifically reacting to their Q4 earnings reports.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 4:31 pm

Vaxxinity Inc (NASDAQ:VAXX) shares dropped 10% to $0.24 due to volatility following the announcement of its voluntary delisting and deregistration from Nasdaq. The decision was made to address non-compliance with the minimum bid price requirement and to focus on R&D without the distraction of stock price fluctuations. Delisting is scheduled for around May 9, with plans to move to over-the-counter trading.

Portfolio Pulse from Henry Khederian

April 23, 2024 | 4:12 pm

U.S. stocks saw gains with the S&P 500 rising over 1%. Zions Bancorporation (ZION) shares increased by 4% after reporting Q1 earnings that exceeded EPS estimates but missed revenue forecasts. Other notable movements included Moolec Science (MLEC), NewGenIvf Group (NIVF), and Matterport (MTTR) experiencing significant gains, while Vaxxinity (VAXX), Hepion Pharmaceuticals (HEPA), and Warrantee (WRNT) saw sharp declines.

Portfolio Pulse from Avi Kapoor

April 22, 2024 | 6:46 pm

Vaxxinity Inc (NASDAQ:VAXX) shares plummeted nearly 50% to $0.25 after announcing plans to voluntarily delist and deregister its Class A common stock due to non-compliance with Nasdaq's minimum bid price requirement. The company aims to concentrate on R&D efforts by eliminating the distractions of stock price fluctuations. Delisting is expected around May 9, with potential over-the-counter trading thereafter.

Portfolio Pulse from Henry Khederian

April 22, 2024 | 5:59 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.